What does CUSIP 10501E951 represent in this 13F holders report?

CUSIP 10501E951 is the security identifier for 10501E951 - BRAINSTORM CELL THERAPEUTICS - PUT used to aggregate holder disclosures.

How many institutions held 10501E951 - BRAINSTORM CELL THERAPEUTICS - PUT in Q2 2021?

No institutional holders were reported for 10501E951 - BRAINSTORM CELL THERAPEUTICS - PUT in Q2 2021; review adjacent reporting periods for trend context.

BRAINSTORM CELL THERAPEUTICS - PUT

CUSIP: 10501E951

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / PUT
Price per share: $3.80
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 10501E951?
CUSIP 10501E951 identifies 10501E951 - BRAINSTORM CELL THERAPEUTICS - PUT in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 10501E951:

Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

BRAINSTORM CELL THERAPEUTICS - PUT

Q2 2021 13F Holders as of 30 Jun 2021

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of BRAINSTORM CELL THERAPEUTICS - PUT as of Q2 2021.